Two clinical trials evaluating cemsidomide — an oral therapy candidate from C4 Therapeutics (C4T) that aims to limit cancer growth — in people with…

Silexion Therapeutics has launched a Phase 2/3 clinical trial testing its experimental therapy SIL204 in combination with standard-of-care chemotherapy in people with pancreatic…

The U.S. Food and Drug Administration (FDA) has granted conditional approval to iberdomide, an oral medication to be used in combination with an antibody-based…